CD8A and non-small cell lung carcinoma: Cytotoxic CD8+T lymphocytes (CTLs) in NSCLC with a high level of CD103 display enhanced cytotoxicity and proliferation, suggesting a robust anti-tumor immune response in human lung cancer (41).